Cargando…

Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clinical care

BACKGROUND: Newly approved, drug-modifying therapies are associated with still unknown adverse events, although clinical trials leading to approval have strict inclusion and exclusion criteria and analyse safety and efficacy. OBJECTIVES: The aim of this study was to analyse the eligibility of multip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jalusic, Kris Oliver, Ellenberger, David, Rommer, Paulus, Stahmann, Alexander, Zettl, Uwe, Berger, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521377/ https://www.ncbi.nlm.nih.gov/pubmed/33467978 http://dx.doi.org/10.1177/1352458520985118

Ejemplares similares

Epileptic seizures at multiple sclerosis onset and their role in disease progression
por: Grothe, Matthias, et al.
Publicado: (2023)

Management of MS Patients Treated With Daclizumab – a Case Series of 267 Patients
por: Rommer, Paulus S., et al.
Publicado: (2020)

Aggressive multiple sclerosis: a matter of measurement and timing
por: Ellenberger, David, et al.
Publicado: (2020)

Treatment patterns in pediatric patients with multiple sclerosis in Germany—a nationwide claim-based analysis
por: Frahm, Niklas, et al.
Publicado: (2021)

Relapsing and progressive MS: the sex-specific perspective
por: Rommer, Paulus Stefan, et al.
Publicado: (2020)

Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry
por: Frahm, Niklas, et al.
Publicado: (2022)

Inclusion and Exclusion Criteria of Clinical Trials for Insomnia
por: Huls, Hendrikje, et al.
Publicado: (2018)

Coping behavior in multiple sclerosis—complementary and alternative medicine: A cross‐sectional study
por: Rommer, Paulus S, et al.
Publicado: (2018)

Editorial: Multiple Sclerosis – From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on Patients
por: Rommer, Paulus S., et al.
Publicado: (2020)

Effects of normobaric hypoxic endurance training on fatigue in patients with multiple sclerosis: a randomized prospective pilot study
por: Zrzavy, Tobias, et al.
Publicado: (2021)

Genetic, Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis
por: Hecker, Michael, et al.
Publicado: (2021)

Vaccination in Multiple Sclerosis: Friend or Foe?
por: Zrzavy, Tobias, et al.
Publicado: (2019)

Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry
por: Ohle, Lisa-Marie, et al.
Publicado: (2021)

Vaccination and multiple sclerosis in the era of the COVID-19 pandemic
por: Monschein, Tobias, et al.
Publicado: (2021)

Therapeutic plasma exchange in steroid-refractory multiple sclerosis relapses. A retrospective two-center study
por: Blechinger, Stephan, et al.
Publicado: (2021)

Inclusion and exclusion criteria in research studies: definitions and why they matter
por: Patino, Cecilia Maria, et al.
Publicado: (2018)

Frequency and Predictors of Relapses following SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis: Interim Results from a Longitudinal Observational Study
por: Frahm, Niklas, et al.
Publicado: (2023)

Application of Statistical Methods for Central Statistical Monitoring and Implementations on the German Multiple Sclerosis Registry
por: Fneish, Firas, et al.
Publicado: (2023)

Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis
por: Zrzavy, Tobias, et al.
Publicado: (2021)

Treatment of the First Acute Relapse Following Therapeutic Plasma Exchange in Formerly Glucocorticosteroid-Unresponsive Multiple Sclerosis Patients—A Multicenter Study to Evaluate Glucocorticosteroid Responsiveness
por: Ehler, Johannes, et al.
Publicado: (2017)

Comparison of employment among people with Multiple Sclerosis across Europe
por: Ellenberger, David, et al.
Publicado: (2022)

Human circadian rhythm studies: Practical guidelines for inclusion/exclusion criteria and protocol
por: Yousefzadehfard, Yashar, et al.
Publicado: (2022)

SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study
por: Frahm, Niklas, et al.
Publicado: (2022)

Die Corona-Pandemie und Multiple Sklerose: Impfungen und deren Implikationen für Patienten – Teil 1: Empfehlungen
por: Monschein, Tobias, et al.
Publicado: (2021)

Die Corona-Pandemie und Multiple Sklerose: Impfungen und deren Implikationen für Patienten – Teil 2: Impfstofftechnologien
por: Monschein, Tobias, et al.
Publicado: (2021)

Inclusions and exclusions
por: Torres, Lourdes
Publicado: (2020)

MetaQC: objective quality control and inclusion/exclusion criteria for genomic meta-analysis
por: Kang, Dongwan D., et al.
Publicado: (2012)

Osteopenia and Total Disc Prosthesis Subsidence: Inclusion/Exclusion Criteria for Total Disc Replacement
por: Lee, Casey K.
Publicado: (2007)

Improving inclusion and exclusion criteria in foodborne illness outbreak investigations: a case study
por: Firestone, M. J., et al.
Publicado: (2020)

Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies
por: Sellner, Johann, et al.
Publicado: (2021)

Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis
por: Monschein, Tobias, et al.
Publicado: (2020)

Inclusión/exclusión : historia con mujeres /
por: Barrancos, Dora
Publicado: (2002)

Equity in Vaccine Trials for Higher Weight People? A Rapid Review of Weight-Related Inclusion and Exclusion Criteria for COVID-19 Clinical Trials
por: Campbell, Jessica, et al.
Publicado: (2021)

Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple Sclerosis
por: Bsteh, Gabriel, et al.
Publicado: (2023)

Clinical scales in autoimmune encephalitis—A retrospective monocentric cohort study
por: Macher, Stefan, et al.
Publicado: (2023)

The changing faces of autism: The fluctuating international diagnostic criteria and the resulting inclusion and exclusion—A Norwegian perspective
por: Chahboun, Sobh, et al.
Publicado: (2022)

Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts
por: Berger, Thomas, et al.
Publicado: (2016)

Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic Rhinitis
por: Kaliner, Michael A, et al.
Publicado: (2009)

Multiple sclerosis and COVID‐19: How many are at risk?
por: Bsteh, Gabriel, et al.
Publicado: (2020)

Time for Inclusion of Racial and Gender Discrimination in Routine Clinical Assessment
por: De Rose, Cristina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4fqk63hv2f99pmi0tolp2bg5lb